California Life Sciences
A public policy research and advocacy organization for California's biomedical industry.
Based in DC
🤖
AI Overview
With $1.1M in lobbying spend across 32 quarterly filings, California Life Sciences is a significant lobbying presence. Their lobbying covers 6 issue areas. Active from 2018 to 2025.
$1.1M
Total Spend
8
Years Active
1
Firms Hired
1
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $120K |
| 2019 | $120K |
| 2020 | $120K |
| 2021 | $120K |
| 2022 | $160K |
| 2023 | $160K |
| 2024 | $160K |
| 2025 | $160K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, Medicare/Medicaid, Taxation, Defense and 1 more
- •Promoted life sciences community and communicated economic and health benefits of the industry.
- •H.R.849/H.J.Res 51: IPAB Repeal Act and Joint Resolution related to IPAB Repeal.
- •H.R. 184: Protect Medical Innovation Act.
- •FY 2018 Continuing resolution as it relates to suspension of the medical device tax.
- •H.R.1892: Bipartisan Budget Act of 2018 as it relates to a Part D donut hole provision and IPAB repeal.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.